Transforming growth factor-β isoforms in mammary neoplasia: More questions than answers
- 1 January 1992
- journal article
- Published by Elsevier in Human Pathology
- Vol. 23 (1) , 1-3
- https://doi.org/10.1016/0046-8177(92)90002-k
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Expression cloning and characterization of the TGF-β type III receptorCell, 1991
- Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor systemCell, 1991
- Expression cloning of an activin receptor, a predicted transmembrane serine kinaseCell, 1991
- The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta.Journal of Clinical Investigation, 1991
- Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1.The Journal of Experimental Medicine, 1990
- Interaction of growth factors during progression towards steroid independence in T‐47‐D human breast cancer cellsJournal of Cellular Biochemistry, 1990
- Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1-growth-inhibited mouse mammary gland.The Journal of cell biology, 1990
- Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell linesJournal of Cellular Physiology, 1989
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.The Journal of Experimental Medicine, 1986